Chromosomal integration of rAAV vectors may induce hepatocellular carcinoma in neonatally treated mice.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Advances in the management of haemophilia: emerging treatments and their mechanisms
Journal of Biomedical Science Open Access 14 September 2021
-
Basic FGF or VEGF gene therapy corrects insufficiency in the intrinsic healing capacity of tendons
Scientific Reports Open Access 11 February 2016
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Donsante, A. et al. Science 317, 477 (2007).
Donsante, A. et al. Gene Ther. 8, 1343–1346 (2001).
http://www4.od.nih.gov/oba/rac/Transcript3-7-011.pdf (2001).
Bell, P. et al. Mol. Ther. 12, 299–306 (2005).
Nakai, H. et al. J. Virol. 75, 6969–6976 (2001).
Nakai, H. et al. Nat. Genet. 34, 297–302 (2003).
Nakai, H. et al. J. Virol. 79, 3606–3614 (2005).
Miller, D.G., Petek, L.M. & Russell, D.W. Nat. Genet. 36, 767–773 (2004).
Inagaki, K. et al. J. Virol., published online 8 August 2007 (doi:10.1128/JVI.00963-07).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kay, M. AAV vectors and tumorigenicity. Nat Biotechnol 25, 1111–1113 (2007). https://doi.org/10.1038/nbt1007-1111
Issue Date:
DOI: https://doi.org/10.1038/nbt1007-1111
This article is cited by
-
Advances in the management of haemophilia: emerging treatments and their mechanisms
Journal of Biomedical Science (2021)
-
Beliefs and Values About Gene Therapy and In-Utero Gene Editing in Patients with Hemophilia and Their Relatives
The Patient - Patient-Centered Outcomes Research (2020)
-
Basic FGF or VEGF gene therapy corrects insufficiency in the intrinsic healing capacity of tendons
Scientific Reports (2016)
-
Protein-anchoring Strategy for Delivering Acetylcholinesterase to the Neuromuscular Junction
Molecular Therapy (2012)
-
rAAV-Mediated Tumorigenesis: Still Unresolved After an AAV Assault
Molecular Therapy (2012)